Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli

Kidney International

Volumn 67, Issue 6, 2005, Pages 2143-2150

  Esposito, Ciro ^a   Parrilla, Bina ^a   De Mauri, Andreana ^a   Cornacchia, Flavia ^a   Fasoli, Gianluca ^a   Foschi, Annalisa ^a   Mazzullo, Tiziana ^a   Plati, AnnaRita ^a   Scudellaro, Roberta ^a   Dal Canton, Antonio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Fibrosis; Glomeruli; HGF; TGF

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GLOMERULUS; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TURNOVER TIME; WESTERN BLOTTING; ZYMOGRAPHY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY GLOMERULUS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 23044468834     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00319.x     Document Type: Article

References (23)

1. ZARNEGAR R, MICHALOPOULOS GK: The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 129:1177-1180,1995
2. MICHIELI P, CAVASSA S, BASILICO C, et al: An HGF-MSP chimera dissociates the trophic properties of scatter factors from their proinvasive activity. Nat Biotechnol 20:488-495,2002
3. MICHIELI P, BASILICO C, PENNACCHIETTI S, et al: Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. Oncogene 18:5221-5231,1999
4. MIZUNO S, MATSUMOTO K, NAKAMURA T: Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney lnt 59:1304-1314,2001
5. INOUE T, OKADA H, KOBAYASHI T, et al: Hepatocyte growth factor counteracts transforming growth factor-β, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J 17:268-275,2003
6. TAKAYAMA H, LAROCHELLE WJ, SABNIS SG: Renal tubular hyperplasia, polycistic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest 77:131-138,1997
7. RAMPINO T, CANCARINI G, GREGORINI M, et al: Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. Am J Pathol 159:1275-1285,2001
8. YANG J, LIU Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13:96-107,2002
9. HE CJ, ESPOSITO C, PHILLIPS C, et al: Dissociation of glomerulosclerosis, glomerular hypertrophy and cell proliferation in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 97:1242-1249,1996
10. ESPOSITO C, FORNONI A, CORNACCHIA F, et al: Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int 58:123-130,2000
11. STRIKER GE, HE CJ, LIU ZH, et al: Pathogenesis of nonimmune glomerulosclerosis: Studies in animals and potential applications to humans. Lab Invest 73:596-605,1995
12. ESPOSITO C, PATEL A, LIU ZH, et al: Involvement of synthesis and degradation pathways of collagen type IV in human glomerulosclerosis: molecular analysis by in situ reverse transcription and competitive polymerase chain reaction. Contrib Nephrol 18:12-16,1996
13. YANG CW, STRIKER LJ, PESCE C, et al: Glomerulosclerosis and body growth are mediated by different portions of bovine growth hor-mone: studies in transgenic mice. Lab Invest 68:62-70,1993
14. LENZ O, ELLIOT SJ, STETLER-STEVENSON WG: Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 11:574-581,2000
15. LIU Y, RAJUR K, TOLBERT E, DWORKIN LD: Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 58:2028-2043,2000
16. BRANTON MH, KOPP JB: TGF-β and fibrosis. Microbes Infect 1:1349-1365, 1999
17. SILBIGER S, LEI J, ZIYADEH FN, NEUGARTEN J: Estradiol reverses TGF-beta 1-stimulated type IV collagen gene transcription in murine mesangial cells. Am J Physiol 274:F1113-F1118,1998
18. YAMAMOTO T, NOBLE NA, MILLER DE, et al: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927,1994
19. ESPOSITO C, STRIKER LJ, PATEL A, et al: Molecular analysis of glomerular diseases in renal biopsies: Initial results of a collaborative international study. Proc Am Soc Phys 108:209-217,1996
20. MIZUNO S, MATSUMOTO K, KUROSAWA T et al: Reciprocal balance of hepatocyte growth factor and transforming growth factor-β1 in renal fibrosis in mice. Kidney Int 57:937-948,2000
21. LIU Y, TOLBERT EM, SUN AM, DWORKIN LD: In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rat. Am J Physiol 271:F1202-F1210,1996
22. FORNONI A, LIH, FOSCHI A, et al: Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol 158:275-280,2001
23. LIU Y, TOLBERT EM, SUN AM, et al: Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells. Am J Physiol 271:F679-F688,1996